Linking Genes to Cardiovascular Diseases: Gene Action and Gene–Environment Interactions

Journal of Cardiovascular Translational Research

Volumn 8, Issue 9, 2015, Pages 506-527

  Pasipoularides, Ares ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Duke NSF Research Center for Emerging Cardiovascular Technologies   (United States)

Author keywords

Environmental influences and epigenetics; Exons, introns, and alternative splicing; Gene interactions and epistasis; Genetic cardiomyopathies, HCM, DCM; Genotype and expressed phenotypes; Major gene, modifier genes, and pleiotropy; Monogenic and polygenic traits and gene networks; Mutations and haplotypes; Regulatory DNA switches and regulation of gene expression

Indexed keywords

DNA; RNA;

ALTERNATIVE RNA SPLICING; CARDIOVASCULAR DISEASE; DATA PROCESSING; DNA MICROARRAY; EXON; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOMIC INSTABILITY; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE MAP; HUMAN; INTRON; NEXT GENERATION SEQUENCING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; EPIGENETICS; EVIDENCE BASED MEDICINE; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOMICS; GENOTYPE; MALE; MUTATION; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY;

CARDIOVASCULAR DISEASES; EPIGENOMICS; EVIDENCE-BASED MEDICINE; FEMALE; GENE REGULATORY NETWORKS; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; GENOTYPE; HUMANS; MALE; MUTATION; PHENOTYPE; SENSITIVITY AND SPECIFICITY;

EID: 84949092787     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-015-9658-9     Document Type: Review

References (150)

1. Wallace, B. (1992). The search for the gene. Ithaca: Cornell University Press.
2. Pasipoularides, A. (2010). Heart's vortex: intracardiac blood flow phenomena. Shelton: People's Medical Publishing House. 960 p.
3. Pasipoularides, A. (2012). Diastolic filling vortex forces and cardiac adaptations: probing the epigenetic nexus. Hellenic Journal of Cardiology, 53, 458–469.
4. Pasipoularides, A. (2015). Mechanotransduction mechanisms for intraventricular diastolic vortex forces and myocardial deformations: Part 1. Journal of Cardiovascular Translational Research, 8, 76–87. doi:10.1007/s12265-015-9611-y.
5. Pasipoularides, A. (2015). Mechanotransduction mechanisms for intraventricular diastolic vortex forces and myocardial deformations: Part 2. Journal of Cardiovascular Translational Research, 8, 293–318. doi:10.1007/s12265-015-9630-8.
6. Lunkenheimer, P. P., Niederer, P., Sanchez-Quintana, D., Murillo, M., & Smerup, M. (2013). Models of ventricular structure and function reviewed for clinical cardiologists. Journal of Cardiovascular Translational Research, 6, 176–186.
7. Johannsen, W. (1909). Elemente der exakten Erblichkeitslehre. Jena: Gustav Fischer.
8. Larribe, F., & Fearnhead, P. (2011). On composite likelihoods in statistical genetics. Stat Sinica, 21, 43–69.
9. Venter, J. C., Adams, M. D., Myers, E. W., et al. (2001). The sequence of the human genome. Science, 291, 1304–1351.
10. International Human Genome Sequencing Consortium. (2001). Initial sequencing and analysis of the human genome. Nature, 409, 860–921.
11. International Human Genome Mapping Consortium. (2001). A physical map of the human genome. Nature, 409, 934–941.
12. International Human Genome Sequencing Consortium. (2004). Finishing the euchromatic sequence of the human genome. Nature, 431, 931–945.
13. Glotov, A. S., Kazakov, S. V., Zhukova, E. A., et al. (2015). Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group. Clinica Chimica Acta, 446, 132–140.
14. Stakos, D. A., & Boudoulas, H. (2002). Pharmacogenetics and pharmacogenomics in cardiology. Hellenic Journal of Cardiology, 43, 1–15.
15. Wheeler, M. T., Ho, M., Knowles, J. W., Pavlovic, A., & Ashley, E. A. (2008). Pharmacogenetics of heart failure: evidence, opportunities, and challenges for cardiovascular pharmacogenomics. Journal of Cardiovascular Translational Research, 1, 25–36.
16. Ware, J. S., John, S., Roberts, A. M., et al. (2013). Next generation diagnostics in inherited arrhythmia syndromes: a comparison of two approaches. Journal of Cardiovascular Translational Research, 6, 94–103.
17. Matkovich, S. J., Van Booven, D. J., Hindes, A., et al. (2010). Cardiac signaling genes exhibit unexpected sequence diversity in sporadic cardiomyopathy, revealing HSPB7 polymorphisms associated with disease. Journal of Clinical Investigation, 120, 280–289.
18. Sakharkar, M. K., Chow, V. T., & Kangueane, P. (2004). Distributions of exons and introns in the human genome. In Silico Biology, 4(4), 387–393.
19. Watson, J. D., Gilman, M., Witkowski, J., & Zoller, M. (1992). Recombinant DNA (2dth ed.). New York: WH Freeman and Company, Scientific American Books.
20. Kan, Z., States, D., & Gish, W. (2002). Selecting for functional alternative splices in ESTs. Genome Research, 12, 1837–1845.
21. de Klerk, E., & 't Hoen, P. A. (2015). Alternative mRNA transcription, processing, and translation: insights from RNA sequencing. Trends in Genetics, 31, 128–139.
22. Pan, Q., Shai, O., Lee, L. J., Frey, B. J., & Blencowe, B. J. (2008). Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature Genetics, 40, 1413–1415.
23. Luco, R. F., Allo, M., Schor, I. E., Kornblihtt, A. R., & Misteli, T. (2011). Epigenetics in alternative pre-mRNA splicing. Cell, 144, 16–26.
24. Wang, E. T., Sandberg, R., Luo, S., et al. (2008). Alternative isoform regulation in human tissue transcriptomes. Nature, 456, 470–476.
25. Celotto, A. M., & Graveley, B. R. (2001). Alternative splicing of the Drosophila Dscam pre-mRNA is both temporally and spatially regulated. Genetics, 159, 599–608.
26. Boley, N., Stoiber, M. H., Booth, B. W., et al. (2014). Genome-guided transcript assembly by integrative analysis of RNA sequence data. Nature Biotechnology, 32(4), 341–346.
27. Nadal-Ginard, B. (1990). Muscle cell differentiation and alternative splicing. Current Opinion in Cell Biology, 2, 1058–1064.
28. Lara-Pezzi, E., Gómez-Salinero, J., Gatto, A., & García-Pavía, P. (2013). The alternative heart: impact of alternative splicing in heart disease. Journal of Cardiovascular Translational Research, 6, 945–955.
29. Weeland, C. J., van den Hoogenhof, M. M., Beqqali, A., & Creemers, E. E. (2015). Insights into alternative splicing of sarcomeric genes in the heart. Journal of Molecular and Cellular Cardiology, 81, 107–113.
30. Pennisi, E. (2012). ENCODE Project writes eulogy for junk DNA. Science, 337, 1159–1160.
31. Hudson, J. E., & Porrello, E. R. (2013). The non-coding road towards cardiac regeneration. Journal of Cardiovascular Translational Research, 6, 909–923.
32. Bernal, J. A. (2013). RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications. Journal of Cardiovascular Translational Research, 6, 956–968.
33. Maurano, M. T., Humbert, R., Rynes, E., et al. (2012). Systematic localization of common disease-associated variation in regulatory DNA. Science, 337, 1190–1195.
34. Thurman, R. E., Rynes, E., Humbert, R., et al. (2012). The accessible chromatin landscape of the human genome. Nature, 489, 75–82.
35. Neph, S., Stergachis, A. B., Reynolds, A., Sandstrom, R., Borenstein, E., & Stamatoyannopoulos, J. A. (2012). Circuitry and dynamics of human transcription factor regulatory networks. Cell, 150, 1274–1286.
36. Deddens, J. C., Colijn, J. M., Oerlemans, M. I., et al. (2013). Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome. Journal of Cardiovascular Translational Research, 6, 884–898.
37. Papait, R., Kunderfranco, P., Stirparo, G. G., Latronico, M. V., & Condorelli, G. (2013). Long noncoding RNA: a new player of heart failure? Journal of Cardiovascular Translational Research, 6, 876–883.
38. Terwilliger, J. D., & Hiekkalinna, T. (2006). An utter refutation of the “Fundamental Theorem of the HapMap.”. European Journal of Human Genetics, 14, 426–437.
39. The International HapMap Consortium. (2005). A haplotype map of the human genome. Nature, 437, 1299–1320.
40. Cohen, J. C., Kiss, R. S., Pertsemlidis, A., Marcel, Y. L., McPherson, R., & Hobbs, H. H. (2004). Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science, 305, 869–872.
41. Glass, D. J. (2010). A critique of the hypothesis, and a defense of the question, as a framework for experimentation. Clinical Chemistry, 56, 1080–1085.
42. Harrington, E. D., Jensen, L. J., & Bork, P. (2008). Predicting biological networks from genomic data. FEBS Letters, 582, 1251–1258.
43. Diez, D., Wheelock, A. M., Goto, S., et al. (2010). The use of network analyses for elucidating mechanisms in cardiovascular disease. Molecular BioSystems, 6, 289–304.
44. Cordeddu, V., Di Schiavi, E., Pennacchio, L. A., Ma'ayan, A., et al. (2009). Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nature Genetics, 41, 1022–1026.
45. Berger, S., Posner, J., & Ma'ayan, A. (2007). Genes2Networks: connecting lists of gene symbols using mammalian protein interactions databases. BMC Bioinformatics, 8(1), 372.
46. Schmitt, T., Ogris, C., & Sonnhammer, E. L. (2013). FunCoup 3.0: database of genome-wide functional coupling networks. Nucleic Acids Research, 42(Database issue), D380–D388.
47. Shannon, P., Markiel, A., Ozier, O., et al. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research, 13, 2498–2504.
48. Moreno-Moral, A., Mancini, M., D'Amati, G., Camici, P., & Petretto, E. (2013). Transcriptional network analysis for the regulation of left ventricular hypertrophy and microvascular remodeling. Journal of Cardiovascular Translational Research, 6, 931–944.
49. Barabási, A. L., Gulbahce, N., & Loscalzo, J. (2011). Network medicine: a network-based approach to human disease. Nature Reviews Genetics, 12, 56–68.
50. Fuxman Bass, J. I., Sahni, N., Shrestha, S., et al. (2015). Human gene-centered transcription factor networks for enhancers and disease variants. Cell, 161, 661–673.
51. Beyer, A., Bandyopadhyay, S., & Ideker, T. (2007). Integrating physical and genetic maps: from genomes to interaction networks. Nature Reviews Genetics, 8, 699–710.
52. Celniker, S. E., Dillon, L. A. L., Gerstein, M. B., et al. (2009). Unlocking the secrets of the genome. Nature, 459, 927–930.
53. Beadle, G. W., & Tatum, E. L. (1941). Genetic control of biochemical reactions in Neurospora. Proceedings of the National Academy of Sciences of the United States of America, 27, 499–506.
54. Mason, P. H. (2010). Degeneracy at multiple levels of complexity. Biological Theory, 5, 277–288.
55. Moffatt, J. D. (2005). What targets have knockouts revealed in asthma? Pharmacology and Therapeutics, 107, 343–357.
56. Baldwin, H. S. (1999). Advances in understanding the molecular regulation of cardiac development. Current Opinion in Pediatrics, 11, 413–418.
57. Goh, K. I., Cusick, M. E., Valle, D., et al. (2007). The human disease network. Proceedings of the National Academy of Sciences of the United States of America, 104, 8685–8690.
58. Austin, E. D., & Loyd, J. E. (2014). The genetics of pulmonary arterial hypertension. Circulation Research, 115, 189–202.
59. Pasipoularides, A. (2014). Galen, father of systematic medicine. An essay on the evolution of modern medicine and cardiology. International Journal of Cardiology, 172, 47–58.
60. Pasipoularides, A. (2014). Historical continuity in the methodology of modern medical science: Leonardo leads the way. International Journal of Cardiology, 171, 103–115.
61. Pasipoularides, A. (2013). Greek underpinnings to his methodology in unraveling De motu cordis and what Harvey has to teach us still today. International Journal of Cardiology, 168, 3173–3182.
62. Pasipoularides, A. (2013). Harvey's epoch-making discovery of the Circulation, its historical antecedents, and some initial consequences on medical practice. Journal of Applied Physiology, 114, 1493–1503.
63. Moss, L. (2003). What genes can't do. Cambridge: MIT Press/Bradford Books.
64. Teekakirikul, P., Kelly, M. A., Rehm, H. L., Lakdawala, N. K., & Funke, B. H. (2013). Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era. Journal of Molecular Diagnostics, 15, 158–170.
65. Friede, K. A., Ginsburg, G. S., & Voora, D. (2015). Gene expression signatures and the spectrum of coronary artery disease. Journal of Cardiovascular Translational Research, 8, 339–352.
66. Su, Z., Ning, B., Fang, H., et al. (2011). Next-generation sequencing and its applications in molecular diagnostics. Expert Review of Molecular Diagnostics, 11, 333–343.
67. Antonarakis, S. E., & Beckmann, J. S. (2006). Mendelian disorders deserve more attention. Nature Reviews Genetics, 7, 277–282.
68. Steinberg, M. H., Forget, P. G., Higgs, D. R., & Nagel, R. L. (Eds.). (2001). Disorders of hemoglobin:genetics, pathophysiology, and clinical management. Cambridge: Cambridge University Press.
69. Kitao, H., & Takata, M. (2011). Fanconi anemia: a disorder defective in the DNA damage response. International Journal of Hematology, 93, 417–424. doi:10.1007/s12185-011-0777-z.
70. The International HapMap Consortium. (2003). The International HapMap Project. Nature, 426, 789–796.
71. Hall, J. L. (2008). Building a program in translational genomics. Journal of Cardiovascular Translational Research, 1, 283–287.
72. Dudley, J. T., Kim, Y., Liu, L., et al. (2012). Human genomic disease variants: a neutral evolutionary explanation. Genome Research, 22, 1383–1394.
73. Rosendaal, F. R. (1993). Venous thrombosis: a multicausal disease. Lancet, 353, 1167–1173.
74. Van Berlo, J. H., Maillet, M., & Molkentin, J. D. (2013). Signaling effectors underlying pathologic growth and remodeling of the heart. Journal of Clinical Investigation, 123, 37–45.
75. Kimura, A. (2010). Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response and beyond. Journal of Human Genetics, 55, 81–90.
76. Hershberger, R. E., Lindenfeld, J., Mestroni, L., Seidman, C. E., Taylor, M. R., & Towbin, J. A. (2009). Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. Journal of Cardiac Failure, 15, 83–97.
77. Gelb, B. D., & Chung, W. K. (2014). Complex genetics and the etiology of human congenital heart disease. Cold Spring Harbor Perspectives in Medicine, 4(7), a013953.
78. Sturm, A. C. (2013). Genetic testing in the contemporary diagnosis of cardiomyopathy. Current Heart Failure Reports, 10, 63–72.
79. Stearns, F. W. (2010). One hundred years of pleiotropy: a retrospective. Genetics, 186, 767–773.
80. Solovieff, N., Cotsapas, C., Lee, P. H., Purcell, S. M., & Smoller, J. W. (2013). Pleiotropy in complex traits: challenges and strategies. Nature Reviews Genetics, 14, 483–495.
81. Kamisago, M., Sharma, S. D., DePalma, S. R., et al. (2000). Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. New England Journal of Medicine, 343, 1688–1696.
82. Pasipoularides, A. (1990). Clinical assessment of ventricular ejection dynamics with and without outflow obstruction. Journal of the American College of Cardiology, 15, 859–882.
83. Georgiadis, J., Wang, M., & Pasipoularides, A. (1992). Computational fluid dynamics of ventricular ejection with and without outflow stenosis. Annals of Biomedical Engineering, 20, 81–97.
84. Pasipoularides, A. (2007). Complementarity and competitiveness of the intrinsic and extrinsic components of the total ventricular load: demonstration after valve replacement in aortic stenosis. American Heart Journal, 153, 4–6.
85. Pasipoularides, A., Shu, M., Shah, A., Womack, M. S., & Glower, D. D. (2003). Diastolic right ventricular filling vortex in normal and volume overload states. American Journal of Physiology - Heart and Circulatory Physiology, 284, H1064–H1072.
86. Pasipoularides, A., Shu, M., Shah, A., Tucconi, A., & Glower, D. D. (2003). RV instantaneous intraventricular diastolic pressure and velocity distributions in normal and volume overload awake dog disease models. American Journal of Physiology - Heart and Circulatory Physiology, 285, H1956–H1965.
87. Pasipoularides A. Analysis of vortex flow imaging in normal and dysfunctional RV’s. American Society of Echocardiography 22nd Annual Scientific Sessions, Montreal, 2011. EE02d - Flow Vortex Imaging; PROLibraries.com. http://www.aseuniversity.org/ase/sessions/search/pasipoularides
88. Pasipoularides, A. (2013). RV/LV diastolic flow field: why are measured intraventricular pressure gradients small? Revista Española de Cardiología, 66, 337–341.
89. Pasipoularides, A. (2013). Evaluation of right and left ventricular diastolic filling. Journal of Cardiovascular Translational Research, 6, 623–639.
90. Pasipoularides, A. (2015). Fluid dynamics of ventricular filling in heart failure: overlooked problems of RV/LV chamber dilatation. Hellenic Journal of Cardiology, 56, 85–95.
91. Pasipoularides, A., Murgo, J. P., Miller, J. W., & Craig, W. E. (1987). Nonobstructive left ventricular ejection pressure gradients in man. Circulation Research, 61, 220–227.
92. Shim, Y., Hampton, T. G., Straley, C. A., Harrison, J. K., Spero, L. A., Bashore, T. M., & Pasipoularides, A. D. (1992). Ejection load changes in aortic stenosis: observations made following balloon aortic valvuloplasty. Circulation Research, 71, 1174–1184.
93. Isaaz, K., & Pasipoularides, A. (1991). Noninvasive assessment of intrinsic ventricular load dynamics in dilated cardiomyopathy. Journal of the American College of Cardiology, 17, 112–121.
94. Bird, J. J., Murgo, J. P., & Pasipoularides, A. (1982). Fluid dynamics of aortic stenosis: subvalvular gradients without subvalvular obstruction. Circulation, 66, 835–840.
95. Pasipoularides, A., Murgo, J. P., Bird, J. J., & Craig, W. E. (1984). Fluid dynamics of aortic stenosis: mechanisms for the presence of subvalvular pressure gradients. American Journal of Physiology, 246, H542–H550.
96. Pasipoularides, A. (1992). Cardiac Mechanics: basic and clinical contemporary research. Annals of Biomedical Engineering, 20, 3–17.
97. Kassem, H. S., Azer, R. S., Saber-Ayad, M., et al. (2013). Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program. Journal of Cardiovascular Translational Research, 6, 65–80.
98. Pasipoularides, A. (2011). Fluid dynamic aspects of ejection in hypertrophic cardiomyopathy. Hellenic Journal of Cardiology, 52, 416–426.
99. Bateman, M. G., Quill, J. L., Hill, A. J., & Iaizzo, P. A. (2013). The clinical anatomy and pathology of the human atrioventricular valves: implications for repair or replacement. Journal of Cardiovascular Translational Research, 6, 155–165.
100. Pasipoularides, A. (2011). LV twisting-and-untwisting in HCM: ejection begets filling. Diastolic functional aspects of HCM. [Progress in Cardiology]. American Heart Journal, 162, 798–810.
101. Craig, W. E., Murgo, J. P., & Pasipoularides, A. (1987). Evaluation of time course of left ventricular isovolumic relaxation in humans. In W. Grossman & B. Lorell (Eds.), Diastolic relaxation of the heart (pp. 125–132). The Hague, Boston: Martinus Nijhoff.
102. Mirsky, I., & Pasipoularides, A. (1990). Clinical assessment of diastolic function. Progress Cardiovascular Diseases, 32, 291–318.
103. Weiner, R. B., & Baggish, A. L. (2014). Acute versus chronic exercise-induced left-ventricular remodeling. Expert Review of Cardiovascular Therapy, 12, 1243–1246.
104. Mirsky, I., & Pasipoularides, A. (1980). Elastic properties of normal and hypertrophied cardiac muscle. Federation Proceedings, 39, 156–161.
105. Pasipoularides, A. (2013). Right and left ventricular diastolic pressure–volume relations: a comprehensive review. Journal of Cardiovascular Translational Research, 6, 239–252.
106. Pasipoularides, A., Mirsky, I., Hess, O. M., Grimm, J., & Krayenbuehl, H. P. (1986). Myocardial relaxation and passive diastolic properties in man. Circulation, 74, 991–1001.
107. Hershberger, R. E., Norton, N., Morales, A., Li, D., Siegfried, J. D., & Gonzalez-Quintana, J. (2010). Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circulation Cardiovascular Genetics, 3, 155–161.
108. Moller, D. V., Andersen, P. S., Hedley, P., et al. (2009). The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. European Journal of Human Genetics, 17, 1241–1249.
109. Marston, S. B. (2011). How do mutations in contractile proteins cause the primary familial cardiomyopathies? Journal of Cardiovascular Translational Research, 4, 245–255.
110. Robinson, P., Griffiths, P. J., Watkins, H., & Redwood, C. S. (2007). Dilated and hypertrophic cardiomyopathy mutations in troponin and a-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments. Circulation Research, 101, 1266–1273.
111. Haldane, J. (1941). The relative importance of principal and modifying genes in determining some human diseases. Journal of Genetics, 41, 149–157.
112. Chen, J., & Chien, K. R. (1999). Complexity in simplicity: monogenic disorders and complex cardiomyopathies. Journal of Clinical Investigation, 103, 1483–1485.
113. Cooper, D. N., Krawczak, M., Polychronakos, C., Tyler-Smith, C., & Kehrer-Sawatzki, H. (2013). Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Human Genetics, 132, 1077–1130.
114. Génin, E., Feingold, J., & Clerget-darpoux, F. (2008). Identifying modifier genes of monogenic disease: strategies and difficulties. Human Genetics, 124, 357–368.
115. Risch, N. J. (2000). Searching for genetic determinants in the new millennium. Nature, 405, 847–856.
116. Rao, D. C. (2008). An overview of the genetic dissection of complex traits. Advances in Genetics, 60, 3–34.
117. Phillips, P. C. (2008). Epistasis--the essential role of gene interactions in the structure and evolution of genetic systems. Nature Reviews Genetics, 9, 855–867.
118. Marian, A. J., & Roberts, R. (2001). The molecular genetic basis for hypertrophic cardiomyopathy. Journal of Molecular and Cellular Cardiology, 33, 655–670.
119. Ooi, C. H., & Tan, P. (2003). Genetic algorithms applied to multi-class prediction for the analysis of gene expression data. Bioinformatics, 19, 37–44.
120. Draghici, S. (2003). Data analysis tools for DNA microarrays. Boca Raton: Chapman & Hall.
121. Bandyopadhyay, S., Maulik, U., & Wang, J. T. L. (Eds.). (2007). Analysis of biological data: a soft computing approach. Singapore/Hackensack: World Scientific.
122. Wakabayashi I, Groschner K (editors). Interdisciplinary concepts in cardiovascular health Volume I: Primary risk factors. Wien/ New York: Springer-Verlag, 2013.
123. Bevilacqua, V., Mastronardi, G., Menolascina, F., Paradiso, A., & Tommasi, S. (2006). Genetic algorithms and artificial neural networks in microarray data analysis: a distributed approach. Engineering Letters, 13, 335–343.
124. Lawrence, J. (1994). Introduction to neural networks: design, theory, and applications (6th ed.). Nevada City: California Scientific Software.
125. Tarasov, K. V., Brugh, S. A., Tarasova, Y. S., & Boheler, K. R. (2007). Serial analysis of gene expression (SAGE): a useful tool to analyze the cardiac transcriptome. Methods in Molecular Biology, 366, 41–59.
126. Kraus, W. E., Granger, C. B., Sketch, M. H., Jr., et al. (2015). A guide for a cardiovascular genomics biorepository: the CATHGEN experience. Journal of Cardiovascular Translational Research. doi:10.1007/s12265-015-9648-y.
127. Douglas, P. S., & Ginsburg, G. S. (2008). Clinical genomic testing: getting it right. Journal of Cardiovascular Translational Research, 1, 17–20.
128. Bodi, V., Marrachelli, V. G., Husser, O., Chorro, F. J., Viña, J. R., & Monleon, D. (2013). Metabolomics in the diagnosis of acute myocardial ischemia. Journal of Cardiovascular Translational Research, 6, 808–815.
129. Krishnamoorthy, P., Gupta, D., Chatterjee, S., Huston, J., & Ryan, J. J. (2014). A review of the role of electronic health record in genomic research. Journal of Cardiovascular Translational Research, 7, 692–700.
130. Rasmussen, L. V. (2014). The electronic health record for translational research. Journal of Cardiovascular Translational Research, 7, 607–614.
131. McKernan, K. J., Peckham, H. E., Costa, G. L., et al. (2009). Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. Genome Research, 19, 1527–1541.
132. Dalton, L., Ballarin, V., & Brun, M. (2009). Clustering algorithms: on learning, validation, performance, and applications to genomics. Current Genomics, 10, 430–445.
133. Bittner, M., Meltzer, P., & Trent, J. (1999). Data analysis and integration: of steps and arrows. Nature Genetics, 22, 213–215.
134. Madeira, S. C., & Oliveira, A. L. (2004). Biclustering algorithms for biological data analysis: a survey. IEEE Transactions on Computational Biology and Bioinformatics, 1, 24–45.
135. Baldi, P., & Hatfield, G. W. (2002). DNA microarrays and gene expression: from experiments to data analysis and modelling. Cambridge: Cambridge Univ. Press.
136. Klugar, Y., Basri, R., Chang, J. T., & Gerstein, M. (2003). Spectral biclustering of microarray data: coclustering genes and conditions,”. Genome Research, 13, 703–716.
137. Nührenberg, T. G., Langwieser, N., Binder, H., et al. (2013). Transcriptome analysis in patients with progressive coronary artery disease: identification of differential gene expression in peripheral blood. Journal of Cardiovascular Translational Research, 6, 81–93.
138. Pontes, B., Girldez, R., & Aguilar-Ruiz, J. S. (2015). Quality measures for gene expression biclusters. PLoS One, 10(3), e0115497.
139. Pontes B, Giráldez R, Aguilar-Ruiz JS. Biclustering on expression data: A review. J Biomed Inform 2015. In press. pii: S1532-0464(15)00138-0. doi:10.1016/j.jbi.2015.06.028
140. Jacob, F., & Monod, J. (1961). Genetic regulatory mechanisms in the synthesis of proteins. Journal of Molecular Biology, 3, 318–356.
141. Kauffman, S. (1969). Homeostasis and differentiation in random genetic control networks. Nature, 224, 177–178.
142. Kitano, H. (2001). Foundations of systems biology. Cambridge: MIT Press.
143. Evans, G. A. (2000). Designer science and the ‘omic’ revolution. Nature Biotechnology, 18, 127.
144. Noble, D. (2013). A biological relativity view of the relationships between genomes and phenotypes. Progress in Biophysics and Molecular Biology, 111, 59–65.
145. King, M. C., & Wilson, A. C. (1975). Evolution at two levels in humans and chimpanzees. Science, 188, 107–116.
146. Enard, W., Khaitovich, P., Klose, J., et al. (2002). Intra- and interspecific variation in primate gene expression patterns. Science, 296, 340–343.
147. Cheung, V. G., & Spielman, R. S. (2002). The genetics of variation in gene expression. Nature Genetics, 32(Suppl), 522–525.
148. Arnaudo, A. M., & Garcia, B. A. (2013). Proteomic characterization of novel histone post-translational modifications. Epigenetics and Chromatin, 6, 24.
149. Jones, M. J., Fejes, A. P., & Kobor, M. S. (2013). DNA methylation, genotype and gene expression: who is driving and who is along for the ride? Genome Biology, 14(7), 126.
150. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215–233.